KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Tax Assets Current Leases Current Taxes Dividends payables Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

West Pharmaceutical Services (WST) Finished Goods (2017 - 2018)

Historic Finished Goods for West Pharmaceutical Services (WST) over the last 5 years, with Q4 2018 value amounting to $81.9 million.

West Pharmaceutical Services' Finished Goods fell 1360.76% to $81.9 million in Q4 2018 from the same period last year, while for Dec 2018 it was $81.9 million, marking a year-over-year decrease of 1360.76%. This contributed to the annual value of $81.9 million for FY2018, which is 1360.76% down from last year.
Latest data reveals that West Pharmaceutical Services reported Finished Goods of $81.9 million as of Q4 2018, which was down 1360.76% from $94.8 million recorded in Q4 2017.
West Pharmaceutical Services' Finished Goods' 5-year high stood at $94.8 million during Q4 2017, with a 5-year trough of $81.9 million in Q4 2018.